Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The impact of osteopontin gene variations on multiple sclerosis development and progression.
New Data Show Longer Tysabri Dosing Interval in MS Is Feasible
Value of the MoCA Test as a Screening Instrument in Multiple Sclerosis.
Grey matter lesions in MS: From histology to clinical implications.
Evoked potential tests in clinical diagnosis.
Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.
miR-17-92 cluster targets Phosphatase and Tensin Homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation.
Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis.
Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing-remitting multiple sclerosis.
Hypoxia Inducible Factor-1α in Astrocytes and/or Myeloid Cells Is Not Required for the Development of Autoimmune Demyelinating Disease(,.)
Multiple sclerosis: A distinct disease course for paediatric multiple sclerosis.
Does HLA Class II Haplotype play a role in Adult Acute Disseminated Encephalomyelitis? Preliminary Findings from a Southern Italy hospital-based study.
Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains.
In vivo imaging of activated microglia in a mouse model of focal cerebral ischemia by two-photon microscopy.
Exploring the potential of public proteomics data.
Tau protein concentrations in the cerebrospinal fluid of children with acute disseminated encephalomyelitis.
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome.
Diagnostic value of 3D fluid attenuated inversion recovery sequence in multiple sclerosis.
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
The Treatment experience, burden, and unmet needs (TRIBUNE) study - measuring the socioeconomic consequences of Multiple Sclerosis.
Acute combined central and peripheral demyelination showing anti-aquaporin 4 antibody positivity.
[Clinical study of optic neuritis combined with viral hepatitis].
Purkinje cell fusion and binucleate heterokaryon formation in multiple sclerosis cerebellum.
Bevacizumab Diminishes Experimental Autoimmune Encephalomyelitis by Inhibiting Spinal Cord Angiogenesis and Reducing Peripheral T-Cell Responses.
Combination of robot-assisted and conventional body-weight-supported treadmill training improves gait in persons with multiple sclerosis: a pilot study.
Pages
« first
‹ previous
…
270
271
272
273
274
275
276
277
278
…
next ›
last »